Skip to main content
Atrás
Watch Compare

Quoin Pharmaceuticals, Ltd.

Calidad de datos: 83%
QNRX
NASDAQ Manufacturing Chemicals
$6.04
▲ $0.12 (2.03%)
Cap. Mercado: 10.19 M
6 months return
—
Momentum
Neutral
ROE
-2364.66%

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -13.54 M

Price History

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-2364.66%
Below sector avg (-54.47%)
ROICN/A
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio1.04
Interest CoverageN/A

Valoración

PE (TTM|NTM)
-0.64 | -1.87
Above sector avg (-1.49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1605 pares)
Métrica Acción Mediana del Sector
P/E -0.6 -1.5
P/B — 1.6
ROE % -2364.7 -54.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Precio Objetivo de Analistas

3 analistas

Consenso de analistas: objetivo medio vs precio actual y calificación.

Strong Buy
Actual
$6.04
+391.2%
Objetivo
$29.67
$14.00
$35.00
$40.00
Pronóstico
P/E Futuro -1.87
EPS Futuro -$3.15
Ingresos Est. 0.0

Estimaciones de Ganancias

Pronósticos de EPS e ingresos por período. Anual = años fiscales; trimestral = próximos trimestres.

Período EPS Est. Ingresos Est. Analistas
FY2027 -$3.15
-$3.15 – -$3.15
0.0 1
FY2026 -$5.55
-$5.55 – -$5.55
0.0 1

Sorpresas de Ganancias

Últimos 4 trimestres
Trimestre EPS Est. EPS Real Sorpresa
Q42025 -$4.02 -$1.74 +56.7%
Q32025 -$1.92 -$6.70 -248.8%
Q22025 -$4.55 -$6.27 -37.9%
Q12025 -$4.20 -$6.50 -54.8%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -15.80 M
ROE -2364.66% ROA -206.11%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -13.54 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1.04
Interest Coverage N/A Asset Turnover N/A
Working Capital 250,779 Tangible Book Value -1.62 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.64 Forward P/E -1.87
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -132.88%
Market Cap 10.19 M Enterprise Value 8.36 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share -7.51 OCF / Share -7.51
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 85.68%
SBC-Adj. FCF -14.72 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — 0.0
Net Income -15.80 M -8.96 M -8.69 M -9.38 M -21.46 M
EPS (Diluted) — — — — -0.01
Gross Profit — — — — —
Operating Income — — — — —
EBITDA — — — — —
R&D Expenses 9.80 M 3.60 M 3.31 M 2.67 M 1.56 M
SG&A Expenses 6.49 M 5.93 M 6.07 M 6.58 M 4.50 M
D&A — — — — —
Interest Expense — — — — 1.09 M
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 20.39 M 15.71 M 12.17 M 14.46 M 9.36 M
Total Liabilities 7.27 M 6.50 M 6.51 M 7.05 M 8.70 M
Shareholders' Equity 13.12 M 9.20 M 5.66 M 7.41 M 657,032.0
Total Debt — — — — —
Cash & Equivalents 3.82 M 3.62 M 2.40 M 2.86 M 7.48 M
Current Assets 20.01 M 14.93 M 11.29 M 13.37 M 8.50 M
Current Liabilities 5.55 M 4.18 M 3.58 M 3.53 M —